Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. (BIO-B) Stock Overview

Explore Bio-Rad Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.

BIO-B●NYSE
HealthcareMedical - Devices
$348.30
$11.30(3.35%)
U.S. Market opens in 2h 54m

Bio-Rad Laboratories, Inc. (BIO-B)

Meyka AI Score

Z

Key Financials

Market Cap9.5B
P/E Ratio43.13
EPS (TTM)$3.37
ROE0.03%
Fundamental Analysis

AI Price Forecasts

1 Month$323.15
3 Months$314.78
1 Year Target$149.89

BIO-B Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Bio-Rad Laboratories, Inc. (NYSE: BIO-B) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Bio-Rad Laboratories, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BIO-B on the NYSE shows an RSI of 92.80, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $149.89 for the NYSE listing.

Key metrics behind Bio-Rad Laboratories, Inc.'s NYSE-traded stock include a P/E ratio of 43.13 and a market capitalization of 9.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BIO-B on the NYSE.

Price Performance (NYSE: BIO-B)

1-Day Change
3.35%
5-Day Change
3.35%
1-Month Change
12.58%
3-Month Change
36.30%
6-Month Change
35.50%
Year-to-Date (YTD) Change
12.10%
1-Year Change
40.98%
3-Year Change
-10.13%
5-Year Change
-54.34%
All-Time (Max) Change
2553.71%

Contact Information

https://www.bio-rad.com
510 724 7000
1000 Alfred Nobel Drive, Hercules, CA, 94547

Company Facts

74,500 Employees
IPO DateSep 21, 1999
CountryUS
Actively Trading

Frequently Asked Questions